Notably, while BRCA1/2 germline variants accounted for 46% (23% in BRCA1 and 23% in BRCA2) of these pathogenic changes, a substantial 54% were found in other breast cancer predisposition genes [2]. This evidence concerns the gene BRCA2 and breast cancer.